Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: A systematic review

References

• Chow W-H, Devesa SS, Warren JL, Fraumeni Jr JF. Rising incidence of renal cell cancer in the United States. JAMA 1999;281:1628–31.
   PubMed Web of Science ®Google Scholar
• Maldazys JD, DeKernion JB. Prognostic factors in metastatic renal carcinoma. J Urol 1986;136:376–9.
   PubMed Web of Science ®Google Scholar
• Flanigan RC, Campbell SC, Clark JI, Picken MM. Metastatic renal cell carcinoma. Curr Treat Options Oncol 2003;4:385–90.
   PubMedGoogle Scholar
• Decker DA, Decker V, Herskovic A, Cummings G. Brain metastases in patients with renal cell carcinoma: Prognosis and treatment. J Clin Oncol 1984;2:169–73.
   PubMed Web of Science ®Google Scholar
• Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679–94.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta- analyses: The PRISMA statement. Ann Intern Med 2009; 151:264–9.
   PubMed Web of Science ®Google Scholar
• Ning S, Trisler K, Wessels BW, Knox SJ. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer 1997;80:2519–28.
   PubMed Web of Science ®Google Scholar
• Ikushima H, Tokuuye K, Sumi M, Kagami Y, Murayama S, Ikeda H, et al. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2000;48:1389–93.
   PubMed Web of Science ®Google Scholar
• Fokas E, Henzel M, Hamm K, Surber G, Kleinert G, Engenhart-Cabillic R. Radiotherapy for brain metastases from renal cell cancer: Should whole-brain radiotherapy be added to stereotactic radiosurgery? Strahlenther Onkol 2010; 186:210–7.
   PubMed Web of Science ®Google Scholar
• Staehler M, Haseke N, Nuhn P, Tüllmann C, Karl A, Siebels M, et al. Simultaneous anti–angiogenic therapy and single–fraction radiosurgery in clinically relevant metastases from renal cell carcinoma. Br J Urol Int 2011;108:673–8.
   Google Scholar
• Goyal LK, Suh JH, Reddy CA, Barnett GH. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2000;47:1007–12.
   PubMed Web of Science ®Google Scholar
• Shuto T, Inomori S, Fujino H, Nagano H. Gamma knife surgery for metastatic brain tumors from renal cell carcinoma. J Neurosurg 2006;105:555–60.
   PubMed Web of Science ®Google Scholar
• Kano H, Iyer A, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases. Neurosurgery 2011;69:1232.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Greco C, Motzer R, Magsanoc JM, Pei X, Lovelock M, et al. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity- modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2012;82:1744–8.
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C, Vogel WJ, Welch WC, Baar J, et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine 2005;3:288–95.
   PubMed Web of Science ®Google Scholar
• Svedman C, Sandström P, Pisa P, Blomgren H, Lax I, Kälkner K-M, et al. A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 2006;45:870–5.
   PubMed Web of Science ®Google Scholar
• Ranck MC, Golden DW, Corbin KS, Hasselle MD, Liauw SL, Stadler WM, et al. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma. Am J Clin Oncol 2013;36:589–95.
   PubMed Web of Science ®Google Scholar
• Balagamwala EH, Angelov L, Koyfman SA, Suh JH, Reddy CA, Djemil T, et al. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma: Clinical article. J Neurosurg Spine 2012;17: 556–64.
   PubMed Web of Science ®Google Scholar
• Nguyen Q-N, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, et al. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010;76:1185–92.
   PubMed Web of Science ®Google Scholar
• Wersäll PJ, Blomgren H, Lax I, Kälkner K-M, Linder C, Lundell G, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005;77:88–95.
   PubMed Web of Science ®Google Scholar
• Vogelbaum MA, Angelov L, Lee S-Y, Li L, Barnett GH, Suh JH. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 2006;104:907–12.
   PubMed Web of Science ®Google Scholar
• Boyd TS, Mehta MP. Stereotactic radiosurgery for brain metastases. Oncology 1999;13:1397.
   PubMed Web of Science ®Google Scholar
• Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, et al. Stereotactic body radiation therapy: A novel treatment modality. Nat Rev Clin Oncol 2009;7:44–54.
   PubMed Web of Science ®Google Scholar
• Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: A systematic review. J Thorac Oncol 2010;5:1091–9.
   PubMed Web of Science ®Google Scholar
• Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. Br J Urol Int 2012;110: E737–43.
   Google Scholar
• Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol 2009;10:718–26.
   PubMed Web of Science ®Google Scholar
• Schaue D, Ratikan JA, Iwamoto KS, McBride WH. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys 2012;83:1306–10.
   PubMed Web of Science ®Google Scholar
• Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg 1993; 79:210–6.
   PubMed Web of Science ®Google Scholar
• Cochran DC, Chan MD, Aklilu M, Lovato JF, Alphonse NK, Bourland JD, et al. The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. J Neurosurg 2012; 116:978–83.
   PubMed Web of Science ®Google Scholar
• Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:847.
   PubMed Web of Science ®Google Scholar